Results 141 to 150 of about 162,990 (305)
Additional file 2: of High-intensity interval training and moderate-intensity continuous training in adults with Crohnâ s disease: a pilot randomised controlled trial
, 2019 Summary of recruitment survey data. (DOCX 12 kb)Tew, Garry, Leighton, Dean, Carpenter, Roger, Anderson, Simon, Langmead, Louise, Ramage, John, Faulkner, James, Coleman, Elizabeth, Fairhurst, Caroline, Seed, Michael, Bottoms, Lindsay +10 moreopenaire +1 more sourceAdditional file 1: of Multi-omics differentially classify disease state and treatment outcome in pediatric Crohn’s disease
, 2018 Figure S1. Stacked bar-chart showing the relative abundance of microbial classes across the metagenomic sequencing data. Figure S2. Stacked bar-chart showing the relative abundance of bacterial classes across the 16S rRNA gene sequencing data. Figure S3.Douglas, Gavin, Hansen, Richard, Jones, Casey, Dunn, Katherine, Comeau, André, Bielawski, Joseph, Tayler, Rachel, El-Omar, Emad, Russell, Richard, Hold, Georgina, Langille, Morgan, Van Limbergen, Johan +11 moreopenaire +1 more sourceIntraosseous sarcoidosis imitating peri‐implantitis: A case study
Clinical Advances in Periodontics, EarlyView.Abstract Background
Sarcoidosis is a multisystem granulomatous disorder of unknown cause, typically affecting the lungs and lymph nodes, but it can also involve the eyes, skin, heart, bones, and other organs. The exact cause is unclear, but genetic factors and environmental triggers like infections, chemicals, or dust may play a role.Magdalena Orlowska, David S. Gottlieb, Kenneth S. Kornman +2 morewiley +1 more sourceAdditional file 1: of Multimodal treatment of perianal fistulas in Crohnâ s disease: seton versus anti-TNF versus advancement plasty (PISA): study protocol for a randomized controlled trial
, 2015 Dates of consent of participating centres.E. De Groof, Buskens, Christianne, Cyriel Ponsioen, Dijkgraaf, Marcel, DâHaens, Geert, Srivastava, Nidhi, Acker, Gijs Van, Jansen, Jeroen, Gerhards, Michael, Dijkstra, Gerard, Lange, Johan, Witteman, Ben, Kruyt, Philip, Pronk, Apollo, Tuyl, Sebastiaan Van, Bodelier, Alexander, Crolla, Rogier, West, Rachel, Vrijland, Wietske, Consten, Esther, Brink, Menno, Tuynman, Jurriaan, Boer, Nanne De, Breukink, Stephanie, Pierik, Marieke, Oldenburg, Bas, Meulen, Andrea Van Der, Bonsing, Bert, Spinelli, Antonino, Danese, Silvio, Sacchi, Matteo, Janindra Warusavitarne, Hart, Ailsa, Yassin, Nuha, Kennelly, Rory, Cullen, Garret, Winter, Desmond, A. Hawthorne, Torkington, Jared, Bemelman, Willem +39 moreopenaire +1 more sourceFinancial Toxicity Associated with Biological Medicines: A Scoping Review
Clinical Pharmacology &Therapeutics, EarlyView.Financial toxicity, defined as the economic burden experienced by patients due to medication and other healthcare costs and their consequences, such as material, psychosocial and behavioral effects, represents a significant concern for individuals receiving biological medicines.Laura Sara Maria Saarukka, Kamilla Yamileva, Kari Linden, Anniina Simonen, Anna‐Riia Holmström +4 morewiley +1 more sourceAdditional file 3: of Prognostic biomarkers to identify patients destined to develop severe Crohnâ s disease who may benefit from early biological therapy: protocol for a systematic review, meta-analysis and external validation
, 2016 Draft search strategy to be used for the PUBMED online database. (DOCX 104 kb)Halligan, Steve, Boone, Darren, Bhatnagar, Gauraang, Ahmad, Tariq, Bloom, Stuart, Rodriguez-Justo, Manuel, Taylor, Stuart, Mallett, Susan +7 moreopenaire +1 more sourceClinical Model‐Informed Precision Dosing Consult Service for Accelerating Personalized Medication in Pediatric Patients
Clinical Pharmacology &Therapeutics, EarlyView.Traditional dosing strategies often rely on a “one‐size‐fits‐all” paradigm, assuming an “average” patient with typical demographic and pharmacological characteristics. In reality, this often overlooks existing between‐patient variability and can lead to suboptimal drug exposure or toxicity. This issue is especially pronounced in pediatric patients, who Zachary L. Taylor, Takanobu Nadai, Kei Irie, Wen Rui Tan, Sanjana Parikh, Anhar Hosawi, Matthijs W. van Hoogdalem, Ronaldo Morales Junior, Sonya Tang Girdwood, Abbie D. Leino, Kana Mizuno, Alexander A. Vinks, Tomoyuki Mizuno +12 morewiley +1 more sourceAdditional file 2: of Prognostic biomarkers to identify patients destined to develop severe Crohnâ s disease who may benefit from early biological therapy: protocol for a systematic review, meta-analysis and external validation
, 2016 PRISMA-P 2015 Checklist. (DOCX 31 kb)Halligan, Steve, Boone, Darren, Bhatnagar, Gauraang, Ahmad, Tariq, Bloom, Stuart, Rodriguez-Justo, Manuel, Taylor, Stuart, Mallett, Susan +7 moreopenaire +1 more source